SCHEMBL4697289

SCHEMBL4697289

O=C(O)Cc1c(Br)csc1O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 4/20 0.36
HSD17B10 Q99714 3/20 0.36
GABRA5 P31644 1/20 0.36
GABRB2 P47870 1/20 0.36
CA2 P00918 1/20 0.34
CAMK2A Q9UQM7 1/20 0.34
GSK3B P49841 2/20 0.34
KDM4E B2RXH2 2/20 0.34
GAA P10253 2/20 0.34
HPGD P15428 2/20 0.34
ALDH1A1 P00352 1/20 0.34
GLA P06280 1/20 0.34
CSNK2A2 P19784 1/20 0.34
CSNK2B P67870 1/20 0.34
CSNK2A1 P68400 1/20 0.34
CSNK2A3 Q8NEV1 1/20 0.34
THRB P10828 1/20 0.33
TSHR P16473 2/20 0.32
GPR35 Q9HC97 4/20 0.32
RGS12 O14924 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4811503 0.81 TSHR (0.42) AKR1B1HSD17B10GABRA5GABRB2GSK3B
SCHEMBL2789591 0.70 GAA (0.42) AKR1B1HSD17B10CA2CAMK2AKDM4E
SCHEMBL4695505 0.69 PTGDR2 (0.34) THRB
SCHEMBL9658959 0.67 AKR1B1 (0.46) AKR1B1HSD17B10GABRB2CA2CSNK2A2
SCHEMBL19475267 0.67 AKR1B1 (0.56) AKR1B1HSD17B10CA2CAMK2AKDM4E
SCHEMBL7961734 0.67 ADAMTS5 (0.40) AKR1B1HSD17B10CA2CAMK2AKDM4E
SCHEMBL4811379 0.67 AKR1B1 (0.49) AKR1B1KDM4EALDH1A1THRB
SCHEMBL27866714 0.65 GABRA5 (0.43) HSD17B10GABRA5GABRB2GSK3BALDH1A1
SCHEMBL9117601 0.64 F11 (0.46) AKR1B1HSD17B10CA2KDM4EGAA
SCHEMBL29188157 0.64 KDM4E (0.46) AKR1B1KDM4EGAAHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569935-B1 HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREOF AND USE OF SAME AS MEDICAMENTS, SUCH AS ANTI-BACTERIAL MEDICAMENTS AND BETA-LACTAMASE INHIBITORS NOVEXEL (FR) 2008-08-20 EP disclosed
EP-1569935-A1 HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREOF AND USE OF SAME AS MEDICAMENTS, SUCH AS ANTI-BACTERIAL MEDICAMENTS AND BETA-LACTAMASE INHIBITORS Aventis Pharma S.A. (FR) 2005-09-07 EP disclosed
WO-2004052891-A1 HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREOF AND USE OF SAME AS MEDICAMENTS, SUCH AS ANTI-BACTERIAL MEDICAMENTS AND BETA-LACTAMASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-06-24 WO disclosed